Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Samuel Wieand

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Chemotherapy sensitivity and response assays: are the ASCO guidelines for clinical trial design too restrictive?H Samuel Wieand
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2005
Randomized phase II trials: what does randomization gain?H Samuel Wieand
Journal of the National Cancer Institute|August 5, 2004
Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01Roy E Smith, Linda Colangelo, H Samuel Wieand, et al.
Cancer|September 26, 2003
The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06Melvin Deutsch, Stephanie R Land, Mirsada Begovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neckZhuo Chen, Xin Zhang, Mengfeng Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trialsJames J Dignam, Yunrong Ye, Linda Colangelo, et al.
The Breast Journal|January 24, 2007
Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?Atilla Soran, Gina D'Angelo, Mirsada Begovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative StudyGeorge P Kim, Linda H Colangelo, H Samuel Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06Jacek A Kopec, Greg Yothers, Patricia A Ganz, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 20, 2005
Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-upJose A Seixas-Silva, Thomas Richards, Fadlo R Khuri, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Chemotherapy sensitivity and response assays: are the ASCO guidelines for clinical trial design too restrictive?H Samuel Wieand
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2005
Randomized phase II trials: what does randomization gain?H Samuel Wieand
Journal of the National Cancer Institute|August 5, 2004
Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01Roy E Smith, Linda Colangelo, H Samuel Wieand, et al.
Cancer|September 26, 2003
The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06Melvin Deutsch, Stephanie R Land, Mirsada Begovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neckZhuo Chen, Xin Zhang, Mengfeng Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trialsJames J Dignam, Yunrong Ye, Linda Colangelo, et al.
The Breast Journal|January 24, 2007
Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?Atilla Soran, Gina D'Angelo, Mirsada Begovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative StudyGeorge P Kim, Linda H Colangelo, H Samuel Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06Jacek A Kopec, Greg Yothers, Patricia A Ganz, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 20, 2005
Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-upJose A Seixas-Silva, Thomas Richards, Fadlo R Khuri, et al.
Pageof 2